Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:17:35 UTC |
---|
Update Date | 2019-07-23 07:15:44 UTC |
---|
HMDB ID | HMDB0061089 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Alpha-hydroxymidazolam |
---|
Description | Alpha-hydroxymidazolam is a metabolite of midazolam. Midazolam, marketed in English-speaking countries under the trade names Dormicum, Hypnovel, and Versed, is a short-acting drug in the benzodiazepine class developed by Hoffmann-La Roche in the 1970s. The drug is used for treatment of acute seizures, moderate to severe insomnia, and for inducing sedation and amnesia before medical procedures. It possesses profoundly potent anxiolytic, amnestic, hypnotic, anticonvulsant, skeletal muscle relaxant, and sedative properties. (Wikipedia) |
---|
Structure | OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12 InChI=1S/C18H13ClFN3O/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)22-9-12-8-21-17(10-24)23(12)16/h1-8,24H,9-10H2 |
---|
Synonyms | Value | Source |
---|
a-Hydroxymidazolam | Generator | Α-hydroxymidazolam | Generator | 1-Hydroxymethylmidazolam | HMDB | 1-OH-MDZ | HMDB | 1-Hydroxymidazolam | HMDB | alpha-Hydroxymidazolam | MeSH |
|
---|
Chemical Formula | C18H13ClFN3O |
---|
Average Molecular Weight | 341.767 |
---|
Monoisotopic Molecular Weight | 341.073117965 |
---|
IUPAC Name | [12-chloro-9-(2-fluorophenyl)-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl]methanol |
---|
Traditional Name | [12-chloro-9-(2-fluorophenyl)-2,4,8-triazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl]methanol |
---|
CAS Registry Number | Not Available |
---|
SMILES | OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12 |
---|
InChI Identifier | InChI=1S/C18H13ClFN3O/c19-11-5-6-16-14(7-11)18(13-3-1-2-4-15(13)20)22-9-12-8-21-17(10-24)23(12)16/h1-8,24H,9-10H2 |
---|
InChI Key | QHSMEGADRFZVNE-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as imidazo[1,5-a][1,4]benzodiazepines. Imidazo[1,5-a][1,4]benzodiazepines are compounds containing an imidazole ring and a 1,4-benzodiazepine ring system, both sharing one nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | Imidazo[1,5-a][1,4]benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Imidazo[1,5-a][1,4]benzodiazepine
- Para-diazepine
- Fluorobenzene
- Halobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- N-substituted imidazole
- Heteroaromatic compound
- Azole
- Imidazole
- Ketimine
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organonitrogen compound
- Organooxygen compound
- Imine
- Primary alcohol
- Aromatic alcohol
- Alcohol
- Organic nitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organohalogen compound
- Organochloride
- Organofluoride
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxymidazolam GC-MS (Non-derivatized) - 70eV, Positive | splash10-056r-5095000000-e86a4f5a0a71a34e350b | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxymidazolam GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9223000000-3f514c7a0258e49e1f65 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxymidazolam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 30V, Positive-QTOF | splash10-00di-0049000000-d895e6063cea9b7a09f0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 50V, Positive-QTOF | splash10-014i-0990000000-77bb23f06e802e59ccd0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Positive-QTOF | splash10-0v6s-0492000000-63c05208d4d7c9ff0b8e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 50V, Positive-QTOF | splash10-014i-0890000000-77bb23f06e802e59ccd0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 10V, Positive-QTOF | splash10-0006-0009000000-1c56560c62733c03b222 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 20V, Positive-QTOF | splash10-0006-0009000000-8c1db0e6fec0c5c5a135 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Positive-QTOF | splash10-0v6s-0492000000-7c15b332e0c6a3e8fe39 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Alpha-hydroxymidazolam 30V, Positive-QTOF | splash10-00di-0049000000-30f3b10d1ecd517c40a6 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 10V, Negative-QTOF | splash10-0006-0009000000-31e0874067a2b92c0d0a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 20V, Negative-QTOF | splash10-01ox-0029000000-ff9099b2ad85a8e30147 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Negative-QTOF | splash10-0006-7091000000-c5de935b2501a445dbe7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 10V, Negative-QTOF | splash10-03dl-0089000000-3044806924cd101e751f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 20V, Negative-QTOF | splash10-00dl-1029000000-77d2ad85be5f7638949e | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Negative-QTOF | splash10-001i-8091000000-9820c5ea13f2c191818c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 10V, Positive-QTOF | splash10-0006-0019000000-66ccd38bae3483f32c1c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 20V, Positive-QTOF | splash10-0006-0029000000-93fa3c07dc10a1af479d | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Positive-QTOF | splash10-0gk9-2691000000-e01f5df13f0f7059a2c5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 10V, Positive-QTOF | splash10-0006-0009000000-90d80e8b23a2763d7125 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 20V, Positive-QTOF | splash10-00dl-0009000000-aa6995ead1e625eff164 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxymidazolam 40V, Positive-QTOF | splash10-05fs-0494000000-d7daea83a7f8e9b0ccda | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|